Skip to content
Use caution Drug recall · FDA · Published January 7, 2013

West-Ward Belladonna Alkaloids Recall: Foreign Substance Hazard

West-Ward recalls Belladonna Alkaloids tablets due to uncharacteristic black spots. Check lot numbers 69099A and 69099B for details.

🇺🇸 FDA recall #D-170-2013DrugWest-Ward Pharmaceutical ›
Take action

Contact the company

Recalling firmWest-ward Pharmaceutical Corp.465 Industrial Way W · Eatontown, NJ 07724-2209
✎ GovInfoNow plain-language explainer

West-Ward Pharmaceutical Corp. is recalling Belladonna Alkaloids (hyoscyamine sulfate, atropine sulfate, scopolamine HBr) with Phenobarbital tablets because they contain uncharacteristic black spots. These foreign substances were found in specific lots of the medication distributed nationwide. The recall involves 6,511 bottles manufactured in Eatontown, NJ. Read more at govinfonow.com/recall/48422-west-ward-pharmaceutical-corp-recalls-belladonna-alkaloids-hyoscyamine-sulfate-usp.

Source Summary by GovInfoNow · govinfonow.com/recall/48422-west-ward-pharmaceutical-corp-recalls-belladonna-alkaloids-hyoscyamine-sulfate-usp · Updated October 13, 2026 · FDA enforcement record: FDA #D-170-2013

Cite this page

“West-Ward Belladonna Alkaloids Recall: Foreign Substance Hazard.” GovInfoNow, updated October 13, 2026. https://govinfonow.com/recall/48422-west-ward-pharmaceutical-corp-recalls-belladonna-alkaloids-hyoscyamine-sulfate-usp. Based on FDA recall #D-170-2013 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-170-2013%22&limit=1).

The FDA announced on Jan. 7, 2013, that West-Ward Pharmaceutical Corp. voluntarily recalled Belladonna Alkaloids Tablets due to the presence of uncharacteristic black spots. The agency classified the recall as Class II.

How to tell if you have it

  • Brand: West-Ward Pharmaceutical
  • Product: Belladonna Alkaloids Tablets
  • NDC 0143-1140-10 (1000-count bottles)
  • NDC 143-1140-51 (5000-count bottles)
  • Lot codes: 69099A, 69099B
  • Expiration date: 08/15

The hazard

The recall was issued because uncharacteristic black spots were found in the tablets. The FDA stated this constitutes the presence of a foreign substance.

Context

GovInfoNow's records show West-Ward Pharmaceutical Corp. has 23 other recalls on record since April 13, 2012. Other recent recalls of similar products include Taro Recalls Children's Ibuprofen Due to Foreign Substance (March 2, 2026), Bionpharma Divalproex Tablets Recall: Foreign Tablets Risk (June 26, 2026), and Lupin prednisolone acetate ophthalmic suspension recall: Foreign substance present (June 4, 2026).

How to tell if you have this one

Check your medication bottle for the brand West-Ward Pharmaceutical Corp. Look for Lot numbers 69099A or 69099B with an expiration date of 08/15. The product is available in 1000-count bottles (NDC 0143-1140-10) and 5000-count bottles (NDC 143-1140-51).

  • Brand
    West-Ward Pharmaceutical
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Your Lot Number

    Verify if your bottle has lot numbers 69099A or 69099B and an expiration date of 08/15.

  2. Contact Your Pharmacist

    Since the remedy is not stated in the record, consult your pharmacist or healthcare provider for instructions on returning or disposing of the medication.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 2 years after the firm started it.

1. Firm started the recall: Jan 7, 201312. FDA classified it Class II: Feb 27, 201323. Published in FDA’s Enforcement Report: Mar 6, 201334. FDA terminated the recall: Jan 21, 2015420132015
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-170-2013 (January 7, 2013) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-170-2013 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 13, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA